PRPF8 and cancer: A pan-cancer analysis revealed the alteration landscape of spliceosome genes across 27 cancer types in 9070 patients, demonstrating both common and specific changes in spliceosome genes among different cancer types, with PRPF8 showing a high mutation rate (7%) [32].